Ovarian Cancer Australia’s symposium was held in Sydney on 10 December 2016. The Symposium featured 12 guest speakers and was well attended by 64 representatives from the gynaecological medical community. The symposium enabled leading international and Australian researchers, clinicians and experts to come together to address and share the latest developments and advances in ovarian cancer research, treatment, genetics and screening.

Prof Ian Jacobs

Presenting on: Population Screening for Early Detection of Ovarian Cancer: the results of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Watch Now

Ms Mary-Anne Young

Presenting on: Offering genetic counselling and BRCA1/2 testing by telephone to Australian women with ovarian cancer.
Watch Now

Prof Jonathan Ledermann

Presenting on: PARP Inhibitors: a quantum leap in therapy for ovarian cancer?
Watch Now

Prof Michael Friedlander

Presenting on: Clinical Trials in Ovarian Cancer: challenges with clinical trial design in the era of targeted therapies.
Watch Now

Dr Rachel Delahunty

Presenting on: TRACEBACK: Identification of women carrying germline BRCA1/2 mutations through a retrospective analysis of patients diagnosed with high grade serous ovarian cancer.
Watch Now

Prof Madeleine King

Presenting on: Quality of life in clinical trials for ovarian cancer: an overview and critique.
Watch Now

Prof Michael Friedlander

Prof Michael Friedlander
Watch Now

Prof David Bowtell

Presenting on: Beating the odds: How some high grade serous ovarian cancer patients become long term survivors.
Watch Now